Undervaluation of arthralgies: role of nurses in early immunotoxicity detection
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://onco.news/index.php/journal/article/view/21 |
Resumo: | The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events or even life threathing. While the majority of toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. We describe a case study in which both performance status and quality of life of a patient where affected by rheumatological toxicity as wells the nurses’ role in the early recognition and toxicity’ management in order to enhance the patient’ quality of life. |
id |
RCAP_9e1636bb06a20dd9de21db508e59fb3a |
---|---|
oai_identifier_str |
oai:oai.onco.news:article/21 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detectionSubvalorização das Artralgias: Papel do Enfermeiro na detecção precoce da ImunotoxicidadeImunoterapiareações adversasImmunotherapycheckpoint inhibitorsimmune-related adverse eventsrheumatic and musculoskeletal diseasesarthralgiasThe use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events or even life threathing. While the majority of toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. We describe a case study in which both performance status and quality of life of a patient where affected by rheumatological toxicity as wells the nurses’ role in the early recognition and toxicity’ management in order to enhance the patient’ quality of life.Os Inibidores do Checkpoint Imunitário (ICI) revolucionaram o tratamento oncológico. Os efeitos adversos da imunoterapia decorrentes da administração dos inibidores do checkpoint imunitário podem ser graves e potencialmente fatais. Embora a maioria das toxicidades seja bem estudada e sobejamente relatada, as complicações reumatológicas são menos reconhecidas e caracterizadas. Descreve-se um estudo de caso em que tanto Performance Status como a qualidade de vida (QdV) de um doente foram afetados pela imunotoxicidade reumatológica bem como o papel do enfermeiro na sua deteção precoce e os cuidados de enfermagem prestados de forma a minimizar o seu impacto na QdV.AEOP – Associação de Enfermagem Oncológica Portuguesa2021-06-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/21Onco.news; No. 42 (2021): Onco.News Journal (january-june); 56-62Onco.News; N.º 42 (2021): Revista Onco.News (janeiro-junho); 56-622183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/21https://onco.news/index.php/journal/article/view/21/26Direitos de Autor (c) 2021 Catarina Almeida, Raquel Chemelainfo:eu-repo/semantics/openAccessAlmeida, CatarinaChemela, Raquel2024-03-16T07:55:10Zoai:oai.onco.news:article/21Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:18.937395Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection Subvalorização das Artralgias: Papel do Enfermeiro na detecção precoce da Imunotoxicidade |
title |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
spellingShingle |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection Almeida, Catarina Imunoterapia reações adversas Immunotherapy checkpoint inhibitors immune-related adverse events rheumatic and musculoskeletal diseases arthralgias |
title_short |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
title_full |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
title_fullStr |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
title_full_unstemmed |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
title_sort |
Undervaluation of arthralgies: role of nurses in early immunotoxicity detection |
author |
Almeida, Catarina |
author_facet |
Almeida, Catarina Chemela, Raquel |
author_role |
author |
author2 |
Chemela, Raquel |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Almeida, Catarina Chemela, Raquel |
dc.subject.por.fl_str_mv |
Imunoterapia reações adversas Immunotherapy checkpoint inhibitors immune-related adverse events rheumatic and musculoskeletal diseases arthralgias |
topic |
Imunoterapia reações adversas Immunotherapy checkpoint inhibitors immune-related adverse events rheumatic and musculoskeletal diseases arthralgias |
description |
The use of immune checkpoint inhibition (ICI) has revolutionized cancer treatment. However, these medications are associated with significant and potentially debilitating immune-related adverse events or even life threathing. While the majority of toxicities have been well studied, rheumatic complications have been less widely recognized and characterized. We describe a case study in which both performance status and quality of life of a patient where affected by rheumatological toxicity as wells the nurses’ role in the early recognition and toxicity’ management in order to enhance the patient’ quality of life. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-07 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://onco.news/index.php/journal/article/view/21 |
url |
https://onco.news/index.php/journal/article/view/21 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://onco.news/index.php/journal/article/view/21 https://onco.news/index.php/journal/article/view/21/26 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2021 Catarina Almeida, Raquel Chemela info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2021 Catarina Almeida, Raquel Chemela |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
dc.source.none.fl_str_mv |
Onco.news; No. 42 (2021): Onco.News Journal (january-june); 56-62 Onco.News; N.º 42 (2021): Revista Onco.News (janeiro-junho); 56-62 2183-6914 1646-7868 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138187143020544 |